Drug · DIN 02408759
NAPROXEN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 6, 2020; first marketed June 1, 2016.
- Drug Identification Number (DIN)
- 02408759
- Company (DIN owner)
- Dominion PharmacalMontreal, Quebec, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Naproxen M01AE02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NAPROXEN SODIUM | 220 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 12, 2017: NOC 19520Abbreviated New Drug Submission (ANDS) · Transfer of drug identification number
- July 29, 2013: NOC 14600Abbreviated New Drug Submission (ANDS) · Administrative licensing agreement between two companies
Other DINs named NAPROXEN
- DIN 02362430 · Marketed
- DIN 02350750 · Cancelled Post Market
- DIN 02350769 · Cancelled Post Market
- DIN 02350777 · Cancelled Post Market
- DIN 02378418 · Cancelled Post Market